Search

Your search keyword '"ONCOL 3: Translational research NCMLS 3: Tissue engineering and pathology."' showing total 18 results
Start Over Descriptor "ONCOL 3: Translational research NCMLS 3: Tissue engineering and pathology." Topic oncol 5: aetiology, screening and detection.
18 results on '"ONCOL 3: Translational research NCMLS 3: Tissue engineering and pathology."'

1. Indium-111-labeled girentuximab immunoSPECT as a diagnostic tool in clear cell renal cell carcinoma.

Author

Muselaers, C.H.J. and Muselaers, C.H.J.

Subjects
ONCOL 3: Translational research., ONCOL 3: Translational research N4i 1: Pathogenesis and modulation of inflammation., ONCOL 3: Translational research NCMLS 2: Immune Regulation., ONCOL 3: Translational research NCMLS 3: Tissue engineering and pathology., ONCOL 4: Quality of Care., ONCOL 5: Aetiology, screening and detection.
Published
2013

4. Phase 1 Radioimmunotherapy Study with Lutetium 177-labeled Anti-Carbonic Anhydrase IX Monoclonal Antibody Girentuximab in Patients with Advanced Renal Cell Carcinoma.

Author

Stillebroer, A.B. and Stillebroer, A.B.

Subjects
NCMLS 2: Immune Regulation ONCOL 3: Translational research., ONCOL 3: Translational research., ONCOL 3: Translational research N4i 1: Pathogenesis and modulation of inflammation., ONCOL 3: Translational research NCMLS 2: Immune Regulation., ONCOL 3: Translational research NCMLS 3: Tissue engineering and pathology., ONCOL 4: Quality of Care., ONCOL 5: Aetiology, screening and detection.
Published
2013

5. A common variant at 8q24.21 is associated with renal cell cancer.

Author

Gudmundsson, J. and Gudmundsson, J.

Subjects
NCEBP 12: Human Reproduction., NCEBP 1: Molecular epidemiology., NCEBP 1: Molecular epidemiology ONCOL 5: Aetiology, screening and detection., ONCOL 3: Translational research NCMLS 3: Tissue engineering and pathology., ONCOL 5: Aetiology, screening and detection.
Published
2013

6. Reply to John Samuel Banerji's Letter to the Editor re: Constantijn H.J. Muselaers, Otto C. Boerman, Egbert Oosterwijk, Johannes F. Langenhuijsen, Wim J.G. Oyen, Peter F.A. Mulders. Indium-111-Labeled Girentuximab ImmunoSPECT as a Diagnostic Tool in Clear Cell Renal Cell Carcinoma. Eur Urol 2013;63:1101-6.

Author

Muselaers, C.H.J. and Muselaers, C.H.J.

Subjects
ONCOL 3: Translational research., ONCOL 3: Translational research N4i 1: Pathogenesis and modulation of inflammation., ONCOL 3: Translational research NCMLS 2: Immune Regulation., ONCOL 3: Translational research NCMLS 3: Tissue engineering and pathology., ONCOL 4: Quality of Care., ONCOL 5: Aetiology, screening and detection.
Published
2013

8. Doxorubicin/cyclophosphamide with concurrent versus sequential docetaxel as neoadjuvant treatment in patients with breast cancer.

Author

Vriens, B.E. and Vriens, B.E.

Subjects
N4i 2: Invasive mycoses and compromised host ONCOL 3: Translational research., NCEBP 2:Evaluation of complex medical interventions ONCOL 4:Quality of Care., NCEBP 4: Quality of hospital and integrated care., NCEBP 4: Quality of hospital and integrated care ONCOL 4: Quality of Care., NCEBP 6: Quality of nursing and allied health care., NCEBP 7: Effective primary care and public health., ONCOL 3: Translational research., ONCOL 3: Translational research NCMLS 3: Tissue engineering and pathology., ONCOL 4: Quality of Care NCEBP 4: Quality of hospital and integrated care., ONCOL 5: Aetiology, screening and detection.
Published
2013

9. Improvement of hospital care for patients with non-Hodgkin's lymphoma: protocol for a cluster randomized controlled trial (PEARL study).

Author

Stienen, J.J.C. and Stienen, J.J.C.

Subjects
N4i 2: Invasive mycoses and compromised host ONCOL 3: Translational research., NCEBP 2:Evaluation of complex medical interventions ONCOL 4:Quality of Care., NCEBP 4: Quality of hospital and integrated care., NCEBP 4: Quality of hospital and integrated care ONCOL 4: Quality of Care., NCEBP 6: Quality of nursing and allied health care., NCEBP 7: Effective primary care and public health., ONCOL 3: Translational research., ONCOL 3: Translational research NCMLS 3: Tissue engineering and pathology., ONCOL 4: Quality of Care NCEBP 4: Quality of hospital and integrated care., ONCOL 5: Aetiology, screening and detection.
Published
2013

10. Dosimetric analysis of 177Lu-cG250 radioimmunotherapy in renal cell carcinoma patients: correlation with myelotoxicity and pretherapeutic absorbed dose predictions based on 111In-cG250 imaging.

Author

Stillebroer, A.B. and Stillebroer, A.B.

Subjects
ONCOL 3: Translational research., ONCOL 3: Translational research N4i 1: Pathogenesis and modulation of inflammation., ONCOL 3: Translational research NCMLS 2: Immune Regulation., ONCOL 3: Translational research NCMLS 3: Tissue engineering and pathology., ONCOL 5: Aetiology, screening and detection.
Published
2012

12. Quantitative short echo time (1) H MRSI of the peripheral edematous region of human brain tumors in the differentiation between glioblastoma, metastasis, and meningioma.

Author

Wijnen, J.P. and Wijnen, J.P.

Subjects
NCEBP 2: Evaluation of complex medical interventions ONCOL 5: Aetiology, screening and detection., ONCOL 3: Translational research., ONCOL 3: Translational research NCMLS 3: Tissue engineering and pathology., ONCOL 3: Translational research NCMLS 4: Energy and redox metabolism., ONCOL 5: Aetiology, screening and detection.
Published
2012

13. Modest improvement in 20 years of kidney cancer care in the Netherlands.

Author

Schans, S.A. van de and Schans, S.A. van de

Subjects
NCEBP 1: Molecular epidemiology ONCOL 5: Aetiology, screening and detection., NCMLS 2: Immune Regulation ONCOL 3: Translational research., ONCOL 3: Translational research., ONCOL 3: Translational research NCMLS 3: Tissue engineering and pathology., ONCOL 5: Aetiology, screening and detection.
Published
2012

15. PD-1 blockade augments Th1 and Th17 and suppresses Th2 responses in peripheral blood from patients with prostate and advanced melanoma cancer.

Author

Dulos, J. and Dulos, J.

Subjects
N4i 4: Auto-immunity, transplantation and immunotherapy NCMLS 2: Immune Regulation., NCEBP 2: Evaluation of complex medical interventions., NCMLS 2: Immune Regulation ONCOL 3: Translational research., ONCOL 3: Translational research., ONCOL 3: Translational research NCMLS 3: Tissue engineering and pathology., ONCOL 3: Translational research NCMLS 6: Genetics and epigenetic pathways of disease., ONCOL 5: Aetiology, screening and detection.
Published
2012

18. Overexpression of the natural antisense hypoxia-inducible factor-1alpha transcript is associated with malignant pheochromocytoma/paraganglioma.

Author

Span, P.N. and Span, P.N.

Subjects
IGMD 6: Hormonal regulation., IGMD 6: Hormonal regulation ONCOL 5: Aetiology, screening and detection., NCEBP 14: Cardiovascular diseases., ONCOL 3: Translational research DCN 2: Functional Neurogenomics., ONCOL 3: Translational research NCMLS 3: Tissue engineering and pathology., ONCOL 5: Aetiology, screening and detection.
Published
2011

Catalog

Books, media, physical & digital resources
See catalog results